Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyclobenzaprine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine hydrochlorid 10mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine hydrochloride 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine hydrochlorid 10mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochlorid 10mg tablet (product) |
Has basis of strength substance (attribute) |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 7.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
Has precise active ingredient |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 7.5 mg oral tablet |
Has precise active ingredient |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochlorid 10mg tablet (product) |
Has precise active ingredient |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 30 mg prolonged-release oral capsule |
Has precise active ingredient |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 30 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Cyclobenzaprine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |